Emily Ouellette has experience in cross-functional project management, integrated program and development team support, and oversight from early stage through phase 3 clinical programs. Emily has clinical expertise in managing all aspects of clinical trials, including protocol development, selecting, and providing oversight of CROs and vendors, and driving product development timelines. At Halloran, Emily supports biotech and medical device clients through strategic management and execution of clinical, regulatory, and quality projects.
Before joining Halloran, Emily worked at PAREXEL where she managed and monitored several multi-center global programs including oncology and hematology studies. Emily also has experience performing organic syntheses in a material science laboratory.